<DOC>
	<DOCNO>NCT01658215</DOCNO>
	<brief_summary>The purpose study compare relative bioavailability nicotine follow repeat application new transdermal formulation reference formulation . Up day 7</brief_summary>
	<brief_title>Nicotine Patch - Multidose Bioequivalence Study</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy subject age 18 45 year ( inclusive ) Current Smoker &gt; = 5 &lt; = 15 cigarettes/day Fagerstr√∂m score &lt; =5 selection Absence clinically significant abnormal find physical , vital sign , Electrocardiogram ECG , biological examination investigator 's opinion . Presence significant medical finding significant history ( particular cardiovascular disease , severe renal hepatic insufficiency , current gastric duodenal ulcer ) may impact safety , interpretation result and/or participation subject study accord opinion investigator Any visible skin disorder , abnormal skin pigmentation dermatologic disease liable interfere use assessment transdermal patch</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Tobacco Use Disorder</keyword>
	<keyword>Central Nervous System Agents</keyword>
</DOC>